Christopher J McDougle, M.D.
This page shows the publications co-authored by Christopher McDougle and Michelle Palumbo.
New-Onset Abnormal Vocalizations in an Adult Woman With Down Syndrome. Psychosomatics. 2020 Nov - Dec; 61(6):804-807.
Pharmacotherapy of Down syndrome. Expert Opin Pharmacother. 2018 Dec; 19(17):1875-1889.
A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology. 2022 Mar 03.
Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. J Dev Behav Pediatr. 2022 01 01; 43(1):38-43.
Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder. Psychopharmacology (Berl). 2019 Oct; 236(10):3045-3061.
Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series. J Autism Dev Disord. 2018 03; 48(3):947-952.
Toward an immune-mediated subtype of autism spectrum disorder. Brain Res. 2015 Aug 18; 1617:72-92.
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. N Engl J Med. 2021 10 14; 385(16):1462-1473.
Selective Serotonin Reuptake Inhibitors for the Treatment of Depression in Adults with Down Syndrome: A Preliminary Retrospective Chart Review Study. Brain Sci. 2021 Sep 15; 11(9).
Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome: a case series. Psychiatr Genet. 2019 04; 29(2):51-56.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.